Suppr超能文献

肾移植术后糖尿病的危险因素。

The risk factors for diabetes mellitus after kidney transplantation.

作者信息

Razeghi Effat, Heydarian Peimaneh, Amerian Monireh, Pourmand Gholamreza

机构信息

Department of Nephrology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Saudi J Kidney Dis Transpl. 2010 Nov;21(6):1038-43.

Abstract

Post-transplant diabetes mellitus (PTDM) is an adverse complication of kidney transplantation, associated with decreased graft and patient survival. We investigated the risk factors for PTDM and their relation to graft rejection in our kidney transplant recipients. We prospectively included 109 consecutive first kidney transplant recipients transplanted at the Sina Hospital in Tehran from June 2003 to May 2004. Patients were excluded if they had diabetes at the time of transplantation either as the cause of kidney failure or as a comorbidity. PTDM was defined by fasting blood sugar ≥126 mg/dL or random blood sugar ≥200 mg/dL on two occasions and the need for insulin therapy and/or oral hypoglycemic drugs for at least two weeks. Thirty non-diabetic transplant recipients were diagnosed as having PTDM during the six month follow-up period after transplantation. Sixty non-PTDM controls, matched for age, sex and immuno-suppressive regimen, and transplanted as closely as possible to the PTDM cases, were randomly selected. The risk factors for PTDM were investigated in these 90 transplant recipients. Age older than 50 years (P = 0.04), history of hypertension (P = 0.02), polycystic kidney disease (P = 0.015), duration on dialysis more than one year (P < 0.0001), family history of diabetes mellitus (P < 0.0001), mean daily dose of prednisolone ≥15 mg/day (P < 0.0001) and cyclosporine ≥240 mg/day (P < 0.0001) were all more in the PTDM group. Also, the mean serum triglycerides was higher (P = 0.019) and there was an increased risk of graft rejection (P < 0.0001) in the PTDM group.

摘要

移植后糖尿病(PTDM)是肾移植的一种不良并发症,与移植肾存活率及患者生存率降低相关。我们对肾移植受者中PTDM的危险因素及其与移植肾排斥反应的关系进行了研究。我们前瞻性纳入了2003年6月至2004年5月在德黑兰新浪医院连续进行首次肾移植的109例受者。如果患者在移植时因肾衰竭或合并症患有糖尿病,则将其排除。PTDM的定义为两次空腹血糖≥126mg/dL或随机血糖≥200mg/dL,且需要胰岛素治疗和/或口服降糖药至少两周。30例非糖尿病移植受者在移植后的6个月随访期内被诊断为患有PTDM。随机选择60例非PTDM对照,这些对照在年龄、性别和免疫抑制方案方面进行匹配,并尽可能与PTDM病例同时进行移植。在这90例移植受者中对PTDM的危险因素进行了研究。PTDM组中年龄大于50岁(P = 0.04)、有高血压病史(P = 0.02)、多囊肾病(P = 0.015)、透析时间超过1年(P < 0.0001)、有糖尿病家族史(P < 0.0001)、泼尼松龙平均每日剂量≥15mg/天(P < 0.0001)和环孢素≥240mg/天(P < 0.0001)的情况均更多。此外,PTDM组的平均血清甘油三酯更高(P = 0.019),且移植肾排斥反应的风险增加(P < 0.0001)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验